Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carotid Baroreflex Activation and Its Effect on the Chemoreflex Study

NCT02210923 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT02210923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02210923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carotid Baroreflex Activation and Its Effect on the Chemoreflex Study
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2013
Completion date
Not reported
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

baroreflex, carotid body, hypertension resistant to conventional therapy